154 related articles for article (PubMed ID: 19682769)
1. Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata.
Talpur R; Vu J; Bassett R; Stevens V; Duvic M
J Am Acad Dermatol; 2009 Oct; 61(4):592.e1-9. PubMed ID: 19682769
[TBL] [Abstract][Full Text] [Related]
2. Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma.
Breneman D; Duvic M; Kuzel T; Yocum R; Truglia J; Stevens VJ
Arch Dermatol; 2002 Mar; 138(3):325-32. PubMed ID: 11902983
[TBL] [Abstract][Full Text] [Related]
3. Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial.
Heald P; Mehlmauer M; Martin AG; Crowley CA; Yocum RC; Reich SD;
J Am Acad Dermatol; 2003 Nov; 49(5):801-15. PubMed ID: 14576658
[TBL] [Abstract][Full Text] [Related]
4. Novel treatment of chronic severe hand dermatitis with bexarotene gel.
Hanifin JM; Stevens V; Sheth P; Breneman D
Br J Dermatol; 2004 Mar; 150(3):545-53. PubMed ID: 15030340
[TBL] [Abstract][Full Text] [Related]
5. Effects of psoralen-UV-A-Turban in alopecia areata.
Broniarczyk-Dyla G; Wawrzycka-Kaflik A; Dubla-Berner M; Prusinska-Bratos M
Skinmed; 2006; 5(2):64-8. PubMed ID: 16603835
[TBL] [Abstract][Full Text] [Related]
6. Bexarotene capsules and gel for previously treated patients with cutaneous T-cell lymphoma: results of the Australian patients treated on phase II trials.
Prince HM; McCormack C; Ryan G; Baker C; Rotstein H; Davison J; Yocum R
Australas J Dermatol; 2001 May; 42(2):91-7. PubMed ID: 11309029
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
Tosti A; Iorizzo M; Botta GL; Milani M
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
[TBL] [Abstract][Full Text] [Related]
8. Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.
Duvic M; Martin AG; Kim Y; Olsen E; Wood GS; Crowley CA; Yocum RC;
Arch Dermatol; 2001 May; 137(5):581-93. PubMed ID: 11346336
[TBL] [Abstract][Full Text] [Related]
9. Long-term control of mycosis fungoides of the hands with topical bexarotene.
Lain T; Talpur R; Duvic M
Int J Dermatol; 2003 Mar; 42(3):238-41. PubMed ID: 12653924
[TBL] [Abstract][Full Text] [Related]
10. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
Olsen EA; Carson SC; Turney EA
Arch Dermatol; 1992 Nov; 128(11):1467-73. PubMed ID: 1444500
[TBL] [Abstract][Full Text] [Related]
11. 3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata.
Fransway AF; Muller SA
Cutis; 1988 Jun; 41(6):431-5. PubMed ID: 3292159
[TBL] [Abstract][Full Text] [Related]
12. Topical and oral bexarotene.
Schadt CR
Dermatol Ther; 2013; 26(5):400-3. PubMed ID: 24099070
[TBL] [Abstract][Full Text] [Related]
13. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis.
Tosti A; Piraccini BM; Pazzaglia M; Vincenzi C
J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016
[TBL] [Abstract][Full Text] [Related]
14. Topical 5-fluorouracil is ineffective in the treatment of extensive alopecia areata.
Kaplan AL; Olsen EA
J Am Acad Dermatol; 2004 Jun; 50(6):941-3. PubMed ID: 15153898
[TBL] [Abstract][Full Text] [Related]
15. Treatment of pediatric alopecia areata with anthralin: A retrospective study of 37 patients.
Wu SZ; Wang S; Ratnaparkhi R; Bergfeld WF
Pediatr Dermatol; 2018 Nov; 35(6):817-820. PubMed ID: 30338548
[TBL] [Abstract][Full Text] [Related]
16. Combination of topical garlic gel and betamethasone valerate cream in the treatment of localized alopecia areata: a double-blind randomized controlled study.
Hajheydari Z; Jamshidi M; Akbari J; Mohammadpour R
Indian J Dermatol Venereol Leprol; 2007; 73(1):29-32. PubMed ID: 17314444
[TBL] [Abstract][Full Text] [Related]
17. Five-year experience in the treatment of alopecia areata with DPC.
El-Zawahry BM; Bassiouny DA; Khella A; Zaki NS
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):264-9. PubMed ID: 19744175
[TBL] [Abstract][Full Text] [Related]
18. Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.
Chua SH; Goh CL; Ang CB
Ann Acad Med Singap; 1996 Nov; 25(6):842-7. PubMed ID: 9055014
[TBL] [Abstract][Full Text] [Related]
19. Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil.
Wang W; Gegentana ; Tonglaga ; Bagenna ; Li Y
J Cosmet Dermatol; 2019 Aug; 18(4):1009-1013. PubMed ID: 31245963
[TBL] [Abstract][Full Text] [Related]
20. Optimizing bexarotene therapy for cutaneous T-cell lymphoma.
Talpur R; Ward S; Apisarnthanarax N; Breuer-Mcham J; Duvic M
J Am Acad Dermatol; 2002 Nov; 47(5):672-84. PubMed ID: 12399758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
